Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | THPO | P40225 | 2/20 | 1.00 |
| ▸ | MTOR | P42345 | 2/20 | 1.00 |
| ▸ | EBP | Q15125 | 2/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.98 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.98 |
| ▸ | DRD2 | P14416 | 13/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | HTR1A | P08908 | 2/20 | 0.64 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.64 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluperidol SCHEMBL29710906 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| Trifluperidol SCHEMBL316725 | 0.99 | PMP22 (1.00) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| Trifluperidol SCHEMBL14973483 | 0.99 | PMP22 (1.00) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| Trifluperidol SCHEMBL28086762 | 0.94 | ABCB11 (0.88) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| Trifluperidol SCHEMBL13724801 | 0.93 | CYP3A4 (0.86) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| SCHEMBL9053345 | 0.92 | ABCB11 (0.85) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| Trifluperidol SCHEMBL5490310 | 0.91 | CYP3A4 (0.83) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| SCHEMBL9053658 | 0.88 | DRD2 (0.82) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| SCHEMBL11373842 | 0.88 | ABCB11 (0.78) | CYP3A4CYP2D6ABCB11TSHRTHPO | |
| SCHEMBL9050645 | 0.87 | DRD2 (1.00) | CYP3A4CYP2D6ABCB11TSHRTHPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2846 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724062-A2 | COMPOSITIONS AND METHODS FOR INCREASING EXPOSURE OF R(-)-MDA | EmpathBio, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4618973-A1 | METHODS OF SWITCHING NEUROPSYCHIATRIC MEDICATIONS USING ULOTARONT | Sumitomo Pharma America, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| US-20250179064-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS LLC | 2025-06-05 | — | — | US | claimed |
| CN-113563246-B | Substituted aza five-membered ring derivative and application thereof in medicines | 广东东阳光药业股份有限公司 | 2025-01-17 | — | — | CN | claimed |
| CN-113563244-B | Substituted aza five-membered ring compound and application thereof in medicine | 广东东阳光药业股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-20240408054-A1 | COMPOSITIONS AND METHODS FOR INCREASING EXPOSURE OF R(-)-MDA | EMPATHBIO, INC. | 2024-12-12 | — | — | US | claimed |
| WO-2024254505-A2 | COMPOSITIONS AND METHODS FOR INCREASING EXPOSURE OF R(-)-MDA | ATAI Life Sciences AG (DE) | 2024-12-12 | — | — | WO | claimed |
| CN-113563245-B | Substituted pyrrolidines and their use in medicine | 广东东阳光药业股份有限公司 | 2024-10-15 | — | — | CN | claimed |
| US-12102640-B2 | Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration | UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2024-10-01 | — | — | US | claimed |
| EP-4398893-A1 | IBOGAINE COMBINATION TREATMENT | atai Life Sciences AG (DE) | 2024-07-17 | — | — | EP | claimed |
| WO-1995032981-A1 | NOVEL GLYCOSIDE COMPOUNDS AND PRODUCTION AND USE THEREOF | HARRIER, INC. (US) | 1995-12-07 | — | — | WO | claimed |
| EP-0441333-B1 | Pharmaceutical composition | SHOWA PHARM CHEM IND (JP) | 1994-05-11 | — | — | EP | claimed |
| US-5118508-A | Butyrophenone compound; vehicle of polyvinyl acetal diethylaminoacetate and polyvinyl pyrrolidone; cataplasm, treatment of vomitting and schizophreneia | SHOWA YAKUHIN KAKO CO., LTD. (JP) | 1992-06-02 | — | — | US | claimed |
| EP-0441333-A1 | Pharmaceutical composition | SHOWA YAKUHIN KAKO CO., LTD. (JP) | 1991-08-14 | — | — | EP | claimed |
| US-4938758-A | Anti-pathogenic blood collection system and method | AL SIOUFI HABIB (US) | 1990-07-03 | — | — | US | claimed |
| EP-0263873-A4 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD. | AL-SIOUFI HABIB | 1989-07-11 | — | — | EP | claimed |
| EP-0263873-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL-SIOUFI, Habib (US) | 1988-04-20 | — | — | EP | claimed |
| WO-1987006119-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL SIOUFI HABIB | 1987-10-22 | — | — | WO | claimed |
| US-4565821-A | 4-PIPERADINO-4*-FLUOROBUTYROPHENONES | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 1986-01-21 | — | — | US | claimed |
| US-3947579-A | HALOGENATED AMINO ACID | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1976-03-30 | — | — | US | claimed |